Schizophrenia & Psychotic Disorders
The US Food and Drug Administration (FDA) has approved a transdermal patch formulation of asenapine (Secuado) as the first patch for the treatment of adults with schizophrenia, Noven Pharmaceuticals, Inc. announced.
The Drug Policy Alliance has introduced what it calls an alternative to abstinence-only prevention curricula for high school students.
With fentanyl driving up overdose-related death rates among patients who relapse, formerly abstinence-based treatment programs are beginning to embrace medication-assisted treatment, says Andrew Stone, MD, MPH.
Abuse, PTSD & Trauma
An international genome-wide association study of 200,000 people has established that the risk of post-traumatic stress disorder (PTSD) is heritable, silencing theories that the disorder is solely a social construct.
Deep brain stimulation of the subcallosal cingulate appears to offer sustained antidepressant efficacy and long-term safety for patients with treatment-resistant depression for up to 8 years.
Child & Adolescent Psychiatry
Smartphone dependency in adolescents predicts loneliness and depression months later, suggests a study published online in the Journal of Adolescent Health.
Cognitive behavioral therapy (CBT) delivered via websites or mobile apps appears beneficial as an addition to usual care in specialty substance use settings or as standalone therapy for alcohol use.